Prior Authorization for GLP-1 Medications: How to Get Insurance Approval

Insurance coverage for GLP-1 weight loss medications is improving but remains inconsistent. Many plans require prior authorization — pre-approval from your insurer before they’ll cover the medication. This process is frustrating by design (insurers save money when patients give up), but it’s navigable if you know what to do.

What Prior Authorization Requires

Your insurer typically needs documentation of medical necessity. This usually includes: confirmed BMI ≥30 (or ≥27 with comorbidities), evidence of failed lifestyle interventions (diet, exercise program attempts documented in your medical record), documentation of weight-related comorbidities (labs showing elevated A1c, blood pressure readings, lipid panels, sleep study results), and sometimes a letter of medical necessity from your prescribing physician.

The Process

1. Your physician submits the PA request with supporting documentation. Some telehealth providers handle this; others require coordination with your primary care physician.
2. The insurer reviews the request (typically 3–15 business days). They may approve, deny, or request additional information.
3. If approved, your pharmacy can fill the prescription under your pharmacy benefit. Copays vary by plan.
4. If denied, you have the right to appeal. First-level appeals are reviewed by the insurer. External appeals go to an independent review organization.

How to Strengthen Your Case

• Document everything. Keep records of diet programs, gym memberships, nutritionist visits, previous weight loss attempts. The more evidence of failed lifestyle interventions, the stronger the medical necessity argument.
• Get the right diagnosis codes. E66.01 (morbid obesity) with additional comorbidity codes (E11 for diabetes, I10 for hypertension) strengthens the case significantly compared to E66.9 (unspecified obesity) alone.
• Include cardiovascular risk. Following the SELECT trial, GLP-1 medications have a cardiovascular indication. If you have established cardiovascular disease or significant risk factors, this creates an additional coverage pathway.
• Appeal every denial. Approximately 50% of first-level appeals for GLP-1 medications are overturned. Many patients give up after the initial denial, which is exactly what insurers count on.